Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Operating Expenses | 14,096 | 10,403 | 10,026 | 10,673 | 11,500 |
Operating Income | -14,096 | -10,403 | -10,026 | -10,673 | -11,500 |
Other Income | 420 | 403 | 249 | 108 | 19 |
Pre-tax Income | -13,676 | -10,000 | -9,777 | -10,565 | -11,481 |
Net Income Continuous | -13,676 | -10,000 | -9,777 | -10,565 | -11,481 |
Net Income | $-13,676 | $-10,000 | $-9,777 | $-10,565 | $-11,481 |
EPS Basic Total Ops | -2.22 | -1.69 | -1.59 | -1.72 | -1.80 |
EPS Basic Continuous Ops | -2.22 | -1.63 | -1.59 | -1.72 | -1.87 |
EPS Diluted Total Ops | -2.22 | -1.69 | -1.59 | -1.72 | -1.80 |
EPS Diluted Continuous Ops | -2.22 | -1.63 | -1.59 | -1.72 | -1.87 |
EPS Diluted Before Non-Recurring Items | -2.25 | -1.65 | -1.65 | N/A | N/A |
EBITDA(a) | $-13,965 | $-10,303 | $-9,885 | $-10,532 | $-11,354 |